Shu Su

417 total citations
26 papers, 280 citations indexed

About

Shu Su is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shu Su has authored 26 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Ophthalmology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shu Su's work include Retinal Diseases and Treatments (5 papers), CAR-T cell therapy research (3 papers) and Glaucoma and retinal disorders (3 papers). Shu Su is often cited by papers focused on Retinal Diseases and Treatments (5 papers), CAR-T cell therapy research (3 papers) and Glaucoma and retinal disorders (3 papers). Shu Su collaborates with scholars based in China, United Kingdom and Taiwan. Shu Su's co-authors include Qiaoli Chen, Shuai Chen, Rongrong Zhu, Mei Yang, Qian Ouyang, Min Li, Fangjun Chen, Huaijin Guan, Baorui Liu and Zhengyun Zou and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Shu Su

25 papers receiving 277 citations

Peers

Shu Su

ONCOL

OPHTH

RNMI

Katleen Brepoels Belgium

Pankaj Panwar India

Nikolaos E. Efstathiou United States

Joshua W. Goldman United States

Masatoshi Murata Japan

Nunciada Salma United States

Faith Kwa Australia

Daniela Géromin France

Edward W. Highsmith United States

Michael O’Hare United Kingdom

Katleen Brepoels Belgium

Shu Su

162 ×1.2

24 ×0.4

ONCOL

12 ×0.3

OPHTH

19 ×0.5

RNMI

118 ×3.3

Citations per year, relative to Shu Su Shu Su (= 1×) peers Katleen Brepoels

Countries citing papers authored by Shu Su

Since Specialization

Citations

This map shows the geographic impact of Shu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Su more than expected).

Fields of papers citing papers by Shu Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Su. The network helps show where Shu Su may publish in the future.

Co-authorship network of co-authors of Shu Su

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Su. A scholar is included among the top collaborators of Shu Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Su. Shu Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Ying, Jia Chen, Shu Su, et al.. (2024). Integrating Multi-omics to Identify Age-Related Macular Degeneration Subtypes and Biomarkers. Journal of Molecular Neuroscience. 74(3). 74–74. 3 indexed citations

Su, Shu, et al.. (2024). The perspective of ceRNA regulation of circadian rhythm on choroidal neovascularization. Scientific Reports. 14(1). 27359–27359. 1 indexed citations

Su, Shu, et al.. (2024). The Effects of STRA6 Regulation of the Circadian Rhythm on Choroidal Neovascularization. Investigative Ophthalmology & Visual Science. 65(11). 21–21. 2 indexed citations

Su, Shu, et al.. (2023). Comparison of three fundus inspection methods during phacoemulsification in diabetic white cataract. International Journal of Ophthalmology. 16(11). 1782–1788. 1 indexed citations

Ouyang, Qian, Qiaoli Chen, Xinyu Yang, et al.. (2023). Rab8a as a mitochondrial receptor for lipid droplets in skeletal muscle. Developmental Cell. 58(4). 289–305.e6. 58 indexed citations

Su, Shu, Xiaojun Fan, Hua Bao, et al.. (2023). Testing the generalizability of cfDNA fragmentomic features across different studies for cancer early detection. Genomics. 115(4). 110662–110662. 3 indexed citations

Quan, Chao, Ruizhen Wang, Qiaoli Chen, et al.. (2022). Impaired SERCA2a phosphorylation causes diabetic cardiomyopathy through impinging on cardiac contractility and precursor protein processing. PubMed. 1(1). 54–66. 4 indexed citations

Chen, Qiaoli, Sheng Yang, Qian Ouyang, et al.. (2022). TRIM24 is an insulin-responsive regulator of P-bodies. Nature Communications. 13(1). 3972–3972. 17 indexed citations

Quan, Chao, Ruizhen Wang, Shu Su, et al.. (2022). The RalGAPα1–RalA signal module protects cardiac function through regulating calcium homeostasis. Nature Communications. 13(1). 4278–4278. 6 indexed citations

10.

Li, Pengfei, et al.. (2022). Cytokines possibly involved in idiopathic epiretinal membrane progression after uncomplicated cataract surgery. Experimental Eye Research. 217. 108957–108957. 5 indexed citations

11.

Fan, Hsiu‐Fang & Shu Su. (2021). The regulation mechanism of the C-terminus of RecA proteins during DNA strand-exchange process. Biophysical Journal. 120(15). 3166–3179. 1 indexed citations

12.

Fan, Hsiu‐Fang, et al.. (2020). Influence of the C-Terminal Tail of RecA Proteins from Alkaline pH-Resistant Bacterium Deinococcus Ficus. ACS Omega. 5(31). 19868–19876. 1 indexed citations

13.

Quan, Chao, Qian Du, Min Li, et al.. (2020). A PKB-SPEG signaling nexus links insulin resistance with diabetic cardiomyopathy by regulating calcium homeostasis. Nature Communications. 11(1). 2186–2186. 40 indexed citations

14.

Shao, Jie, Qiuping Xu, Shu Su, et al.. (2018). Artificial antigen-presenting cells are superior to dendritic cells at inducing antigen-specific cytotoxic T lymphocytes. Cellular Immunology. 334. 78–86. 16 indexed citations

15.

Yang, Mei, Junfang Zhang, Shu Su, et al.. (2018). Allelic interaction effects of DNA damage and repair genes on the predisposition to age-related cataract. PLoS ONE. 13(4). e0184478–e0184478. 4 indexed citations

16.

Wei, Jia, Jing Yan, Shu Su, et al.. (2018). A phase I/II Trial of CRISPR-Cas9-mediated PD-1 knockout Epstein-Barr virus cytotoxic lymphocytes (EBV-CTLs) for advanced stage EBV associated malignancies.. Journal of Clinical Oncology. 36(15_suppl). TPS3118–TPS3118. 6 indexed citations

17.

Shao, Jie, Qiuping Xu, Shu Su, et al.. (2017). Engineered cells for costimulatory enhancement combined with IL-21 enhance the generation of PD-1-disrupted CTLs for adoptive immunotherapy. Cellular Immunology. 320. 38–45. 7 indexed citations

18.

Chen, Fangjun, Zhengyun Zou, Juan Du, et al.. (2017). Feasible and efficient identification of neoantigens for personalized cancer immunotherapy in advanced refractory epithelial cancer patients.. Journal of Clinical Oncology. 35(15_suppl). 3046–3046. 34 indexed citations

19.

Su, Shu, Mei Yang, Nan Hu, et al.. (2016). Association of ZNF644, GRM6, and CTNND2 genes with high myopia in the Han Chinese population: Jiangsu Eye Study. Eye. 30(7). 1017–1022. 16 indexed citations

20.

Su, Shu, et al.. (2013). The relationship between apolipoprotein CIII gene polymorphism and serum lipid levels in Han Chinese males. Meta Gene. 1. 58–64. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact